---

Transudative vs. Exudative Pleural Effusion

---

Definition

• Transudative effusion: Results from alteration of systemic factors (hydrostatic/oncotic pressures) without pleural disease. The pleura itself is normal.
• Exudative effusion: Results from alteration of local factors — inflammation, infection, or malignancy affecting the pleura or adjacent structures.

---

Pathophysiology

---

Common Causes

Transudative Effusion (CHANT mnemonic)

1. Cardiac failure — Left ventricular failure (most common cause overall)
2. Hepatic cirrhosis — hepatic hydrothorax (via diaphragmatic defects)
3. Albuminuria/Nephrotic syndrome — hypoalbuminaemia
4. Nephritic/Renal failure — fluid overload
5. Thyroid — hypothyroidism (myxoedema)
6. Constrictive pericarditis
7. Meigs' syndrome (ovarian fibroma + right-sided effusion + ascites)
8. Superior vena cava obstruction

Exudative Effusion

1. Infection: Parapneumonic effusion, empyema, tuberculosis (important in India)
2. Malignancy: Lung carcinoma, metastatic disease, mesothelioma, lymphoma
3. Pulmonary embolism (can be either, but usually exudate)
4. Connective tissue disease: SLE, rheumatoid arthritis
5. Post-cardiac injury: Dressler's syndrome
6. Pancreatitis — left-sided effusion with high amylase
7. Subphrenic abscess
8. Drug-induced: Amiodarone, methotrexate, nitrofurantoin
9. Chylothorax: thoracic duct disruption

Clinical relevance for India: Tuberculous pleural effusion is a leading cause of exudative effusion in the Indian subcontinent and must always be considered.

---

Diagnostic Approach

Step 1 — Thoracentesis & Pleural Fluid Analysis

Step 2 — Light's Criteria (R.W. Light, 1972) ★★★

• Sensitivity: ~98% for exudate
• Specificity: ~83% for exudate
• If none of these criteria are met → Transudate
• Note: Light's criteria can misclassify ~25% of cardiac failure patients on diuretics as exudates — in such cases, check the serum-to-fluid albumin gradient (>1.2 g/dL = transudate).

---

Additional Pleural Fluid Parameters

---

Clinical Features

History & Symptoms

• Dyspnoea (proportional to size of effusion)
• Pleuritic chest pain — suggests exudate (pleural inflammation)
• Cough, fever — suggests infection/TB
• Features of underlying cause (pedal oedema in CCF, jaundice in cirrhosis, weight loss in malignancy)

Examination Findings

---

Investigations

1. Chest X-ray: Blunting of costophrenic angle (>200 mL); homogeneous opacity; tracheal and mediastinal shift
2. Chest Ultrasonography: First-line to detect and guide thoracentesis; detects as little as 20 mL
3. CT thorax: Evaluates lung parenchyma, pleural thickening, masses
4. Pleural biopsy: For suspected TB or malignancy (Abrams or CT-guided)
5. CECT abdomen: If hepatic or subphrenic cause suspected
6. Sputum AFB, Mantoux, IGRA: For TB workup
7. Serum protein, albumin, LDH, BNP: For Light's criteria and cardiac causes

---

Management

Transudate

• Treat the underlying cause primarily:
  • CCF → diuretics, ACE inhibitors
  • Cirrhosis → diuretics, TIPS, salt restriction
  • Nephrotic syndrome → treat cause, albumin supplementation
• Therapeutic thoracentesis if symptomatic dyspnoea (remove ≤1.5 L at a time to avoid re-expansion pulmonary oedema)

Exudate

• Parapneumonic/Empyema: Antibiotics ± chest tube drainage; pH <7.2 or glucose <40 mg/dL → mandatory drainage; fibrinolytics (streptokinase) if loculated
• TB: Anti-tubercular therapy (ATT) as per NTEP/RNTCP guidelines; corticosteroids may reduce fibrous thickening
• Malignant: Therapeutic thoracentesis; pleurodesis (talc/bleomycin) for recurrent effusions; indwelling pleural catheter
• Rheumatoid/SLE: Treat underlying disease; corticosteroids
• Pulmonary embolism: Anticoagulation

---

Complications of Pleural Effusion

• Empyema (infected exudate)
• Fibrothorax (pleural fibrosis from chronic exudate)
• Tension hydrothorax (rare)
• Re-expansion pulmonary oedema (post-rapid drainage)
• Respiratory failure

---

Summary Table — Key Differences

---

Examiner's tip: Always mention Light's criteria by name with all three parameters — it is the single most important and most commonly asked aspect of this topic. In the Indian context, always include TB as a leading cause of exudative effusion. For a 15-mark question, covering pathophysiology, Light's criteria, causes, investigations, and management is essential.

---

TRANSUDATIVE vs. EXUDATIVE PLEURAL EFFUSION

---

1. DEFINITION

• Transudate: Fluid accumulates due to alteration of systemic factors (↑ hydrostatic pressure or ↓ oncotic pressure) without any intrinsic pleural disease.
• Exudate: Fluid accumulates due to alteration of local factors — inflammation, infection, or malignancy involving the pleura or adjacent structures.

---

2. PATHOPHYSIOLOGY

---

3. CAUSES

Transudative Effusion (CHANT)

Exudative Effusion

⚠️ India-specific point: TB pleural effusion is the most common cause of exudative effusion in the Indian subcontinent and must be the first differential considered in any young patient with exudative effusion.

---

4. CLINICAL FEATURES

Symptoms

• Dyspnoea — proportional to volume of effusion
• Pleuritic chest pain — sharp, worse on inspiration; suggests exudate (pleural inflammation)
• Cough — dry, non-productive
• Fever, night sweats, weight loss — suggests TB or malignancy
• Symptoms of underlying disease: pedal oedema (CCF), jaundice (cirrhosis), haemoptysis (lung Ca)

Signs (Classic Triad on Affected Side)

---

5. INVESTIGATIONS

A. Imaging

• Chest X-ray (PA view):
  • Blunting of costophrenic angle — detects >200 mL
  • Homogeneous opacity with concave (meniscus) upper border
  • Tracheal and mediastinal shift in massive effusion
  • Fluid in fissures (pseudotumour sign in CCF)
• Chest Ultrasonography (first-line): Detects as little as 20 mL; guides safe thoracentesis
• CT thorax: Evaluates pleural thickening, masses, nodules, underlying lung disease

B. Diagnostic Thoracentesis (Key Investigation)

C. Blood Investigations

• CBC, ESR, CRP, LFT, RFT, serum albumin, serum LDH
• BNP / NT-proBNP → CCF
• ANA, anti-dsDNA → SLE
• Mantoux test, IGRA (TB-Gold) → TB
• Sputum AFB × 3

---

6. LIGHT'S CRITERIA ⭐⭐⭐ (Most Important)

• Sensitivity: ~98% | Specificity: ~83%
• If none of the three criteria are met → Transudate

🔑 Important exception: Patients with CCF on diuretics may have falsely exudative fluid by Light's criteria. In such cases, apply the Serum–Pleural Fluid Albumin Gradient:

• Gradient > 1.2 g/dL → Transudate (overrules Light's criteria)

---

7. COMPARISON TABLE — PLEURAL FLUID ANALYSIS

---

8. MANAGEMENT

Transudative Effusion

• Primary goal: Treat underlying cause
  • CCF → Diuretics (furosemide + spironolactone), ACE inhibitors, salt restriction
  • Cirrhosis → Diuretics, TIPS, low-sodium diet
  • Nephrotic syndrome → Treat primary cause, albumin infusion
• Therapeutic thoracentesis if symptomatic (limit to ≤1.5 L per session to prevent re-expansion pulmonary oedema)

Exudative Effusion

---

9. COMPLICATIONS

1. Empyema — infected exudative effusion
2. Fibrothorax — fibrosis from chronic exudate → restrictive lung disease
3. Re-expansion pulmonary oedema — rapid drainage of >1.5 L
4. Respiratory failure — massive effusion
5. Tension hydrothorax — rare; haemodynamic compromise

---

10. QUICK SUMMARY

---

Examiner's Must-Know Points:

• Always name all 3 criteria of Light with exact cut-off values
• Mention the albumin gradient exception for diuretic-treated CCF patients
• ADA > 40 IU/L is the single most important marker for TB effusion in India
• pH < 7.2 is the threshold for mandatory chest tube placement in parapneumonic effusion
• Differentiate stony dull percussion (effusion) from dull percussion (consolidation)